Leerink, Piper Sandler, Guggenheim and LifeSci Capital are acting as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Abivax announces $400M ADS offering
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Trump announces tariff deal with Japan, AT&T reports Q2 beat: Morning Buzz
- Abivax price target raised to $101 from $45 at LifeSci Capital
- Abivax upgraded to Overweight from Equal Weight at Morgan Stanley